Risk assessment in patients with acute myocardial infarction treated with thrombolytic therapy

Journal of Internal Medicine

Volumn 249, Issue 6, 2001, Pages 527-537

  Jensen Urstad, M ^a   Samad, B A ^b   Jensen Urstad, K ^a   Hulting, J ^b   Ruiz, H ^b   Bouvier, F ^b   Hojer J ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Myocardial infarction; Prognosis; Risk assessment; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; FEMALE; FIBRINOLYTIC THERAPY; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 0034857038     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2001.00838.x     Document Type: Article

References (33)

1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
2. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction
3. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival study (CONSENSUS)
4. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
5. Determinants of 5-month mortality in survivors of myocardial infarction after thromb-olysis, results of the GISSI-2 data base
6. Prognostic value of exercise testing soon after myocardial infarction
7. Evaluation of patients after acute myocardial infarction, indications for cardiac catheterization and surgical intervention
8. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction
9. Ability of dipyridamole-thallium-201 imaging 1-4 days after myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events
10. The influence of thrombolytic therapy on the predictive value of exercise testing 3 weeks after acute myocardial infarction
11. A metaanalysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging
12. Has thrombolytic therapy changed the equation for postinfarction risk stratification?
13. Determinants of prognosis in survivors of myocardial infarction
14. Effects of age, gender, and body habitus on regional myocardial isotope uptake in healthy subjects
15. Prognostic value of symptom limited versus low level exercise stress test before discharge in patients with myocardial infarction treated with thrombolytics
16. Comparison of different echocardiographic methods to radionuclide imaging for measuring left ventricular ejection fraction after myocardial infarction treated by thrombolytic therapy
17. Heart rate variability in healthy subjects is related to age and gender
18. Spectrum analysis in a modern perspective
19. Stability over time of heart period variability in patients with previous myocardial infarction and ventricular arrhythmias
20. Quantitative adenosine 201 Tl single-photon emission computed tomography for the early assessment of patients surviving acute myocardial infarction
21. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction
22. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction
23. Heart rate variability as a menas of assessing prognosis after acute myocardial infarction
24. Delayed recovery of myocardial perfusion in acute myocardial infarction: A scintigraphic study after early thrombolytic treatment
25. ISIS-3: A randomised comparison of streptokin-ase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41, 299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survive)
26. Six-month survival in 20,891 patients with acute myocardial infarction randomized between alteplase and streptokinase with or without heparin
27. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial
28. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction
29. Spontaneous delayed recovery of perfusion and contraction after the first 5 weeks after anterior infarction
30. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results
31. SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction
32. Coronary artery bypass surgery after thrombolytic therapy in the thrombolysis in myocardial infarction trial, phase II (TIMI II)